Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Assist. Prof. Dr. Alejandro Rojas | Austral University of Chile | Germany

Dr. Alejandro Alfredo Rojas Fernández is a distinguished Chilean molecular biotechnologist and neuroscientist, currently serving as CEO of Berking Theranostics UG in Hamburg, Germany, and Assistant Professor at the Universidad Austral de Chile. With over two decades of research spanning neurodegeneration, immunology, and viral pathogenesis, Dr. Rojas-Fernández has emerged as a leading expert in molecular diagnostics and theranostics. His innovative work has significantly impacted global health, notably through his contributions to SARS-CoV-2 research and senolytic therapies. A dual academic and entrepreneur, he bridges fundamental science and clinical application, actively publishing in top-tier journals such as Nature Aging, Molecular Psychiatry, and Journal of Cell Biology. Fluent in interdisciplinary collaboration, his efforts have been internationally recognized with multiple honors. With a passion for translational science, Dr. Rojas-Fernández continues to inspire the next generation of biomedical innovators through mentorship and leadership in biotechnology and neuroscience.

Publication Profile:

Orcid

Education:

Dr. Alejandro Rojas-Fernández earned his PhD in Biology from the University of Konstanz, Germany (2006–2010), where his research focused on the regulation of Hdm2/HdmX-mediated ubiquitination and neddylation—mechanisms central to protein stability and cancer biology. Prior to his doctorate, he completed his engineering degree in Molecular Biotechnology (2004–2005) and his B.Sc. in Molecular Biotechnology Engineering (2000–2004) at the Faculty of Sciences, University of Chile—one of Latin America’s leading research institutions. His multidisciplinary education integrates molecular biology, neurobiology, immunology, and translational medicine, equipping him with the foundational and advanced tools to tackle complex biomedical challenges. Dr. Rojas-Fernández’s academic training has been marked by academic excellence and international mobility, enabling him to collaborate and lead research projects across Europe and Latin America.

Experience:

Dr. Rojas-Fernández brings over 20 years of experience in translational biomedical research, academia, and biotech innovation. As CEO of Berking Theranostics UG, he spearheads the development of personalized diagnostic platforms and therapeutics, with a focus on neurodegenerative and inflammatory diseases. In his role as Assistant Professor at Universidad Austral de Chile (20% appointment), he leads the Medical Biotechnology Laboratory within the Centre for Interdisciplinary Studies on the Nervous System (CISNe), contributing to scientific training and cutting-edge research. He previously trained and collaborated at institutions such as the University of Dundee, University of Queensland, and University of Constance, advancing molecular mechanisms of SUMOylation, proteostasis, inflammasome biology, and viral-host interactions. His interdisciplinary expertise allows him to translate complex cellular insights into tangible clinical applications, and his leadership has resulted in high-impact publications, product pipelines, and strategic biotech partnerships in Europe and Latin America.

Awards and Honors:

Dr. Rojas-Fernández has received multiple prestigious honors recognizing his innovative biomedical research. In February 2025, he was named “Innovator of the Month” by Hamburg Invest for groundbreaking biotech contributions in Germany. He was awarded the Medal of the City of Valdivia for his vital role in controlling the SARS-CoV-2 pandemic, one of the highest local honors in Chile. Additionally, he received the 2nd of October Medal for Science and Innovation, recognizing his scientific leadership in Chile’s Los Ríos region. These accolades underscore his impact on global public health, neurodegenerative research, and biotechnology entrepreneurship. His consistent recognition reflects a career dedicated to translational excellence, fostering international collaboration, and advancing science for the benefit of society. His scientific achievements continue to inspire innovation and interdisciplinary approaches within the global scientific community.

Research Focus:

Dr. Alejandro Rojas-Fernández’s research centers on cellular stress responses, ubiquitin/SUMO signaling, neurodegeneration, and host-pathogen interactions. A core focus is the molecular crosstalk between autophagy, protein quality control, and inflammasome activation in brain and immune cells. He has made significant advances in understanding the effects of SARS-CoV-2 on microglia, mechanisms of senescence in aging brains, and nanobody-based viral neutralization. His studies also explore the intersection of endoplasmic reticulum stress and neurodegenerative pathways, using high-content screening and proteomics to uncover therapeutic targets. He actively translates molecular insights into diagnostics and theranostic tools, positioning him at the forefront of personalized medicine. As CEO of a biotech startup, he is developing platforms that integrate biomarker discovery with AI for neuroinflammation profiling. His research bridges fundamental biology and clinical applications, promoting innovative therapies for Alzheimer’s, Parkinson’s, cancer, and viral infections.

Publications Top Notes: 

  1. Negative Modulation of Macroautophagy by Stabilized HERPUD1… – Front Cell Dev Biol, 2022

  2. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia… – Mol Psychiatry, 2022

  3. The p97/VCP segregase is essential for arsenic-induced degradation of PML… – J Cell Biol, 2023

  4. Lack of Parkinsonian Pathology after Proteasome Inhibitor Injection… – Front Aging Neurosci, 2021

  5. NSPA modulates postsynaptic NMDAR stability… – BMC Biol, 2020

  6. Role of PSMD14 in Golgi-to-ER transport and APP processing – Cells, 2020

  7. WDR90 in NLRC4 inflammasome and Salmonella resistance – Dev Comp Immunol, 2019

  8. Proteomic identification of APC interaction partners – Mol Cancer Res, 2019

  9. DHX15 regulates CMTR1-dependent gene expression – Life Sci Alliance, 2018

  10.  Membrane ruffling by polarized stim1 and orai1 – Sci Reports, 2017

Conclusion:

Dr. Alejandro Alfredo Rojas Fernández stands out as a pioneering researcher who consistently delivers scientifically rigorous, socially impactful, and clinically relevant work. His career spans critical sectors—basic research, applied biotechnology, and public health—making him a model example of the translational scientist. With accolades from both European and Latin American institutions and a track record of high-impact publications, Dr. Rojas exemplifies what it means to be a globally relevant and community-driven scientist. His work during the COVID-19 pandemic, innovations in molecular neuroscience, and leadership in therapeutic biotechnology underscore his immense value to the global research community. In conclusion, he is not only a suitable but a highly deserving candidate for the Best Researcher Award.

Hansong Dong | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Prof. Hansong Dong | Host-Pathogen Interactions | Best Researcher Award

Prof. Hansong Dong, Shandong Agricultural University, China

Dr. Hansong Dong is a distinguished Professor of Plant Pathology and Doctoral Supervisor at Shandong Agricultural University, China. With a Ph.D. in Plant Pathology, his work spans over four decades, focusing on plant immunity, signal transduction, and the balance between crop growth and defense. A renowned researcher and published poet, Prof. Dong has made seminal contributions to our understanding of aquaporins, hormone signaling, and the molecular interface between host plants and pathogens. His international academic exposure, including time as a Visiting Scholar at Cornell University, has further enriched his scientific insights. In addition to his impactful research, Prof. Dong has mentored numerous graduate students and contributed to agricultural innovation. With numerous high-impact publications in journals like Molecular Plant and New Phytologist, his work is widely recognized. Beyond academia, his literary works reflect a philosophical appreciation of nature and resilience, exemplifying a rare integration of science and art.

Publication Profile: 

Scopus

Education:

Prof. Hansong Dong pursued his undergraduate studies in Plant Protection at Shandong Agricultural University (1978–1982). He continued with his Master’s and Ph.D. in Plant Pathology at Nanjing Agricultural University, completing them in 1985 and 1988, respectively. His academic training provided a solid foundation in plant-microbe interactions, molecular biology, and host defense mechanisms. During his studies, he honed his focus on understanding plant immune responses, laying the groundwork for his future breakthroughs in signaling and aquaporin-mediated defense. His Ph.D. thesis contributed to early models of pathogen-host dynamics in crops, marking the start of a lifelong research trajectory in agricultural biotechnology. His formal education not only established his credibility in plant pathology but also shaped his vision for interdisciplinary research. Prof. Dong’s academic excellence has continued to drive forward key discoveries in the field, making him a leading authority in crop protection and molecular plant immunity in China and internationally.

Experience:

Prof. Dong began his career as a Lecturer in the Department of Plant Pathology at Shandong Agricultural University (1988–1993). He quickly rose through academic ranks—Associate Professor in 1993, and full Professor by 1994. His leadership and research capabilities were recognized early on, leading to a Visiting Scholar position at Cornell University (1997–2000), where he engaged in collaborative projects on plant immune signaling and pathogen effectors. Over his decades of teaching and research, Prof. Dong has supervised numerous doctoral students, published extensively, and shaped academic policy and curriculum in plant pathology. His tenure at Shandong Agricultural University is marked by scientific rigor, mentorship, and impactful agricultural innovations. His ability to bridge laboratory research with field application has contributed significantly to crop disease management strategies in China. Prof. Dong remains actively involved in national and international research initiatives, playing a vital role in advancing molecular plant pathology and crop resilience.

Awards & Honors:

Prof. Hansong Dong has received several prestigious accolades recognizing his early and sustained contributions to science and education. In 1992, he was honored as an Outstanding Young Intellectual and received the Shandong Youth Science and Technology Award, acknowledging his early promise in agricultural research. The same year, he was also named an Excellent Young Teacher, a testament to his pedagogical contributions. In 1993, he was recognized as a New Long March Commando, symbolizing excellence in youth-led scientific advancement in China. These early recognitions paved the way for a prolific academic career that has garnered respect across disciplines. His awards highlight his leadership in scientific innovation, commitment to nurturing the next generation of researchers, and the societal relevance of his work in safeguarding global food security. As both a scientist and educator, Prof. Dong’s accolades reflect his well-rounded excellence and continued influence in plant pathology and agronomic science.

Research Focus:

Prof. Dong’s research focuses on signal transduction in plant disease resistance and the regulation of growth-defense trade-offs in crops. His work investigates the molecular dialogue between plants and pathogens, particularly through the lens of aquaporins, importins, and membrane proteins. He has significantly advanced our understanding of how pathogenic effectors manipulate host splicing and hormone pathways, notably through TAL effectors and NPR1/NPR3 systems in rice. His team applies multi-omics and CRISPR-based editing to engineer resistant crops while minimizing yield penalties, a critical goal in sustainable agriculture. By elucidating the roles of H2O2 transport, type-III secretion systems, and transcriptional regulation, his research offers translational solutions to fungal and bacterial diseases in cereals like rice and wheat. Prof. Dong’s innovative blend of molecular biology, bioinformatics, and field experimentation drives progress toward disease-resilient, high-yield crops. His collaborative, systems-level approach continues to shape modern plant pathology and crop biotechnology.

 Publications Top Notes:

  1. Alternative splicing of OsNPR3… enhances disease susceptibility in rice – Molecular Plant, 2025

  2. Plant PI4P is required for bacteria to translocate type-3 effectors – New Phytologist, 2025

  3. MYB44 regulates PTI via EIN2 and MPK3/6 in Arabidopsis – Plant Communications, 2023

  4. Importin β1 mediates nuclear entry of EIN2C against aphids – IJMS, 2023

  5. Phosphorylation of wheat aquaporin enhances growth and defense – Molecular Plant, 2022

  6. Aquaporin OsPIP2;2 links H2O2 signaling to plant defense – Plant Physiology, 2022

  7. Editing rice importin IMPα1b sequesters TAL effectors – Phytopathology Research, 2022

  8. Aquaporin modulation intensifies photosynthesis and disease resistance – Plant Journal, 2021

  9. OsPIP2;2 facilitates drought tolerance in rice – Plant Direct, 2021

  10.  Aquaporin TaPIP2;10 confers dual fungal resistance in wheat – Phytopathology, 2021

Conclusion:

Prof. Hansong Dong is highly suitable for the “Best Researcher Award.” His scholarly depth, sustained academic leadership, groundbreaking findings in plant pathology, and dedication to mentoring make him a standout candidate. His career exemplifies a blend of scientific rigor, poetic vision, and global relevance. Recognizing Prof. Dong would not only honor an exceptional researcher but also inspire younger generations in the intersection of science and humanity.

Kwaghgba Elijah Gbabe | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Dr. Kwaghgba Elijah Gbabe | Cell Structure Analysis | Best Researcher Award

Dr. Kwaghgba Elijah Gbabe | Nigerian Stored Products Research Institute | Nigeria

Engr. Dr. Kwaghgba Elijah Gbabe is a seasoned Senior Research Officer at the Nigerian Stored Products Research Institute (NSPRI), Ilorin, Nigeria. With over nine years of progressive research experience, he specializes in food processing, postharvest technology, and agricultural nanotechnology. He is a trailblazer in developing electrospun hexanal nanofiber matrices aimed at extending the shelf-life of fruits such as bananas, mangoes, and tomatoes. His research integrates innovative preservation technologies to enhance food quality and sustainability. A COREN-certified engineer and postgraduate fellow, Dr. Gbabe has collaborated internationally, notably with the Centre for Agricultural Nanotechnology in India. With extensive publications and conference contributions, he is an advocate of research-driven food security and sustainable packaging. He brings a multidisciplinary edge to the evolving field of agricultural innovation, focusing on reducing postharvest losses and increasing storage efficiency in sub-Saharan Africa.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Innovative Research in Agricultural Nanotechnology

    • Pioneered the development of electrospun hexanal nanofiber matrices for fruit shelf-life extension — an emerging and impactful technology in food preservation.

  2. Strong Publication Record 

    • Over a dozen peer-reviewed journal articles and conference papers published across international and national platforms with DOIs, indicating high-quality scholarly contribution.

  3. Hands-On International Collaboration 

    • Completed a research internship at TNAU, India, and collaborated with renowned global experts like Prof. K.S. Subramanian in nanoscience.

  4. Multi-disciplinary Skills 

    • Expertise in advanced instrumentation (FTIR, GC-MS, SEM, TEM) and statistical tools (R, SPSS) shows broad technical competence.

  5. Real-world Application & Societal Impact 

    • Focuses on postharvest technologies to reduce food losses, enhance food safety, and support smallholder farmers and artisans.

  6. Leadership and Mentorship

    • Supervises junior staff, fabricators, and trainees, and contributes to capacity building through training workshops.

  7. Recognized Academic Achievement 

    • Recipient of the Benue State University Postgraduate Fellowship (2020–2025).

Areas for Improvement:

  1. Technology Commercialization and Patenting

    • While research output is strong, translating research into commercial products or patents could increase impact.

  2. Broader International Visibility

    • Participation in more international consortia or grants (e.g., EU Horizon, USAID, FAO) could elevate the global footprint.

  3. Expanded Multidisciplinary Outreach

    • Could integrate more with biotech and AI in agri-research, especially in smart packaging and AI-driven postharvest solutions.

Education:

Dr. Gbabe is currently pursuing his Ph.D. in Food Processing and Technology at Benue State University, Makurdi (2020–2025), with a research focus on developing electrospun hexanal nanofiber matrices for fruit preservation. He holds a Master of Engineering in Agricultural and Environmental Engineering from the University of Agriculture, Makurdi (2017–2019), where his thesis explored eco-building materials using rice husk and sawdust. His undergraduate and professional training background is further enhanced by a Certificate in Computer Appreciation (2010), an internship at the Centre for Agricultural Nanotechnology, TNAU, India (2023), and registration with COREN (2024). Dr. Gbabe is also a member of the Nigerian Institution of Agricultural Engineers (NIAE-M2207), demonstrating a strong foundation in both academic knowledge and regulatory standards in engineering and food technology. His educational pursuits reflect a consistent drive toward sustainability, innovation, and technological adaptation in agricultural systems.

Experience:

Dr. Gbabe serves as a Senior Research Officer at NSPRI since 2016, where he leads projects on postharvest technology, storage engineering, and food shelf-life enhancement. His duties span experimental design, research data analysis, technical report writing, equipment fabrication supervision, and stakeholder training. He has been instrumental in developing novel postharvest technologies and electrospun hexanal nanofiber matrices for fruit preservation. In 2023, he completed a research internship at the Centre for Agricultural Nanotechnology, TNAU, India, gaining hands-on experience in nanotoxicity, food nanotechnology, and biosafety. Dr. Gbabe is known for his interdisciplinary collaboration, capacity-building initiatives, and extensive field and lab-based research. He also coordinates training programs for artisans, farmers, and students. His rich professional journey is marked by impactful project execution, community-focused technology dissemination, and consistent contributions to national and international research publications.

Research Focus:

Dr. Gbabe’s research is centered on postharvest loss reduction, sustainable food preservation, and agricultural nanotechnology. He is pioneering the use of electrospun hexanal nanofiber matrices to extend the shelf-life of perishable fruits like bananas, mangoes, and tomatoes—a major advancement in food storage technology. His work addresses the chemical and biological challenges in postharvest handling, integrating advanced techniques such as FTIR, GC-MS, SEM, and TEM to monitor quality and degradation. He is also exploring green materials for packaging and eco-friendly building solutions using agricultural waste like rice husks and sawdust. His international collaboration with TNAU, India, expanded his research in nanotoxicity and food safety. With a focus on experimental design, interdisciplinary innovation, and practical application, Dr. Gbabe contributes to the development of scalable, cost-effective technologies tailored for African agricultural ecosystems. His goal is to enhance food security through intelligent preservation methods and sustainable postharvest engineering.

Publication Top Notes:

  1.  Effect of Hexanal Nano-fiber Matrix on Quality Parameters of Tomato Fruits during Storage

  2.  Development of Novel Hexanal Nano-fibre Matrix by Electrospinning for Shelf-life Extension of Mango Fruits

  3.  Implication of Different Storage Techniques on Physical Attributes of African Okra (Abelmoschus esculentus)

  4.  Maize Grains Milling Efficiency: A Performance Analysis of a Hammer Mill

  5.  Insecticidal and Toxicity Studies of Heliotropium Indicum Leaf Extracts for Stored Grain Pest Control

  6.  Commercial Utilization of Inert Atmosphere Silo for Maize Storage

  7.  Chemical and Physico-chemical Properties of OFSP Chips Dried Using Solar Dryers

  8.  Evaluation of the Use of Rice Husk in Producing Eco-Building Materials

  9.  Pros and Cons of AI Thermal Imaging in Postharvest Handling of Agricultural Products

  10.  Development of Hexanal Electrospun Nano-fiber Matrix for Banana Preservation

Conclusion:

Engr. Dr. Kwaghgba Elijah Gbabe is an exemplary researcher who combines scientific rigor, technological innovation, and practical application in the field of food systems and agricultural engineering. His pioneering work in nanotechnology, coupled with his leadership in postharvest technology, makes him exceptionally deserving of the Best Researcher Award.

Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Prof. Dr. Raphael Borie, APHP, France

Dr. Raphaël Borie, born on August 15, 1977, in Paris, France, is a leading expert in pulmonology and genetic respiratory diseases. Currently a University Professor Hospital Practitioner at Bichat Hospital (Paris Cité University), he has consistently contributed to the advancement of respiratory medicine, particularly in the field of interstitial lung diseases (ILDs). His clinical insight, combined with a strong research portfolio, has positioned him as a prominent figure within the OrphaLung network. A dedicated family man with two children, Dr. Borie is widely respected for his integrity, leadership, and commitment to collaborative medicine. His career reflects a unique blend of academic excellence and impactful translational research, bridging the gap between genomics and clinical care in ILD. He is a registered member of the French Medical Council (Ordre des Médecins No. 75/71138), and his research has influenced European clinical guidelines and improved the understanding of rare genetic pulmonary conditions.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Robust Academic Background:
    Dr. Borie holds a PhD in Genetics, Master’s in Physiology, and HDR (habilitation to supervise doctoral research), which underlines his scientific credibility and ability to lead independent research.

  2. Clinical-Research Integration:
    As a University Professor and Hospital Practitioner, he merges frontline patient care with cutting-edge genetic and respiratory disease research.

  3. High Publication Impact:
    With 283 PubMed-indexed articles and an H-index of 60, Dr. Borie’s work demonstrates strong citation influence, indicating widespread recognition and utility in the scientific community.

  4. International Leadership:
    Active in multinational collaborations (e.g., OrphaLung, ERS), he has co-authored major position statements and clinical trials, influencing European respiratory care guidelines.

  5. Innovation in Rare Diseases:
    A recognized expert in familial interstitial lung disease and telomere disorders, his work has led to earlier diagnosis and targeted therapies—critical in fields where few experts exist.

  6. Recognition and Funding:
    He has secured prestigious mobility grants (ERS, Respirology Teachers College)—a marker of trust in his scientific mission and innovation.

🔍 Areas for Improvement:

  • Wider Public Health Translation: While Dr. Borie’s genomic research is exceptional, expanding into real-world health policy implementation could enhance systemic impact.

  • Patient Engagement & Advocacy: Developing patient-oriented tools or registries (e.g., digital apps or platforms for familial lung diseases) may broaden his outreach beyond academia and clinics.

  • Broader Visibility: Although highly cited in professional circles, participation in international keynote talks, editorial leadership, or mainstream health media could elevate his public and professional visibility.

🎓 Education:

Dr. Borie has pursued an extensive and rigorous academic path focused on respiratory and genetic medicine. He obtained his medical degree with specialization in Allergology and Immunopathology in 2006. A year earlier, in 2005, he earned a Master’s degree in Biology and Physiology of Circulation and Respiration. Demonstrating deep interest in genetics, he completed a PhD in Genetics in 2017, contributing significantly to our understanding of genetic underpinnings in pulmonary fibrosis. In 2019, Dr. Borie achieved the prestigious Habilitation à Diriger des Recherches (HDR) from the University of Paris 7, enabling him to supervise doctoral research. His academic background illustrates a powerful integration of clinical expertise and molecular research—providing him with the tools to lead innovative research projects at the intersection of genomics and pulmonology.

🩺 Experience:

Dr. Raphaël Borie has over 15 years of experience in respiratory medicine. From July 2011 to August 2020, he served as a Hospital Practitioner in the Pneumology Department at Bichat Hospital under Professors Aubier and Crestani. Since September 2020, he has been a University Professor Hospital Practitioner in the same department, affiliated with Paris Cité University. He has contributed to patient care, education of medical students and residents, and cutting-edge research. As part of the OrphaLung network, he plays a critical role in advancing diagnostic tools and treatment approaches for rare lung diseases. He is recognized for his collaborative leadership and interdisciplinary contributions across genetics, immunology, and pulmonology. His international collaborations and authorship of over 280 PubMed-indexed publications demonstrate his ongoing commitment to improving patient outcomes through translational research.

🏆 Awards and Honors:

Dr. Borie’s research excellence has been recognized through several prestigious awards and scholarships. In 2017, he received the European Respiratory Society (ERS) Mobility Grant for his work on Identification of Preclinical Markers of Pulmonary Fibrosis, supporting international collaboration and advanced training. The same year, he was also honored with the Respirology Teachers College Mobility Grant, reinforcing his pioneering research on early detection of fibrotic lung disease. His selection for these awards highlights both scientific innovation and dedication to knowledge exchange. His leadership in multi-center studies and involvement in ERS guideline statements further reflect his status as a thought leader in interstitial lung disease. These honors are a testament to his influence in shaping the future of pulmonary genetics and translational respiratory medicine.

🔬 Research Focus:

Dr. Raphaël Borie’s research centers on familial and genetic interstitial lung diseases, particularly the molecular mechanisms behind pulmonary fibrosis, telomere biology, surfactant-related gene variants, and early detection strategies. He works extensively on identifying genetic risk variants (e.g., MUC5B, DSP) and their implications in idiopathic pulmonary fibrosis. Through his participation in the OrphaLung network, he supports genomic screening for hereditary lung disorders and contributes to developing European guidelines. His work bridges genomic medicine and clinical pulmonology, aiming for earlier diagnosis and personalized treatment approaches. He has led and co-authored critical studies on RTEL1 mutations, telomerase complex defects, and familial ILD phenotypes, helping clinicians globally understand the heterogeneity and systemic implications of genetic lung disorders. His collaborative international research ensures his findings are applied in practice to optimize long-term patient care.

📚Publications Top Notes:

  • 🧬 High risk of lung cancer in surfactant-related gene variant carriers – Eur Respir J, 2024

  • 📄 European Respiratory Society Statement on Familial Pulmonary Fibrosis – Eur Respir J, 2022

  • 🧪 Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants – Am J Respir Crit Care Med, 2022

  • 🧬 RTEL1 mutations and their phenotypic variability – Eur Respir J, 2019

  • 💊 Safety and efficacy of pirfenidone in telomerase mutation carriers – Eur Respir J, 2018

  • 🌐 Diagnosis and follow-up of familial ILD: International survey – BMC Pulmonary Med, 2025

  • 🧬 New 2023 ACR/EULAR APS criteria performance in young patients – Letter, 2025

  • 🫁 A non-resolving cough: a case of familial pulmonary fibrosis – Breathe, 2025

  • 🧬 PFMG2025: Genomic medicine in French healthcare system – Review, 2025

  • 💊 Efficacy of CFTR modulators in ABCA3-deficiency ILD – Open Access, 2025

  • 🧠 Neurological manifestations in VEXAS syndrome – Journal of Neurology, 2025

  • 💉 Real-life use of PEXIVAS reduced-dose regimen in vasculitis – Ann Rheum Dis, 2025

  • 🧫 Recurrent respiratory papillomatosis with lung involvement – Eur Respir J, 2025

  • 🔍 RA-ILD: genetics to clinical overview – Review, 2025

  • 👶 Childhood ILD survivors in adulthood: European study – Eur Respir J, 2025

🧾 Conclusion:

Dr. Raphaël Borie exemplifies the ideal candidate for the Best Researcher Award. His excellence spans across clinical expertise, academic distinction, and international research leadership, especially in genetic and familial interstitial lung diseases—a field with enormous unmet need. His consistent scholarly output, impactful collaborations, and patient-focused studies highlight a unique blend of depth and innovation. While further expansion into public health frameworks and patient engagement tools would be valuable, his profile already reflects a world-class researcher with transformative contributions to pulmonary medicine.

Yang Liu | Cell Migration Studies | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Yang Liu | Cell Migration Studies | Best Researcher Award

Prof. Dr. Yang Liu, Taiyuan University of Technology Institute of Biomedical Engineering CHINA, China

Dr. Yang Liu is an Associate Professor at the Institute of Biomedical Engineering, Taiyuan University of Technology, China. Since joining in 2013, Dr. Liu has focused on biomechanics, particularly the mechanical mechanisms involved in skin tissue damage and healing processes during traumatic events like burns and radiotherapy. Her interdisciplinary work bridges molecular, cellular, and tissue-level studies to better understand the interplay between mechanical factors and skin regeneration. Her research also extends into the development and structural optimization of biomedical materials such as tissue-engineered skins and advanced dressings. Dr. Liu has led several research and teaching reform projects, obtained a patent transformation, and contributed to national and provincial-level scientific investigations. Her innovative work in tissue engineering and skin trauma treatment continues to contribute significantly to biomedical science and material engineering.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Specialized Expertise
    Dr. Liu focuses on biomechanics in disease development, particularly related to cutaneous trauma (e.g., burns, radiotherapy), a niche but critical area in biomedical engineering.

  2. Material Innovation
    Her work in developing tissue-engineered skin and antibacterial dressings demonstrates applied innovation with potential clinical relevance.

  3. Project Leadership
    Successfully led and participated in multiple competitive research projects funded by national and provincial bodies, indicating trust in her scientific vision and capabilities.

  4. Research Productivity
    Though early in recognition, Dr. Liu has already co-authored several peer-reviewed journal articles in reputable publications like Scientific Reports and Placenta, which reflect growing academic contribution.

  5. Translational Research
    Her involvement in a patent achievement transformation shows a commitment to moving research beyond the lab into real-world applications.

🔧 Areas for Improvement:

  1. Citation Impact and Indexing
    The provided articles currently have 0 citations, and there is no citation index or h-index reported. Increasing publication visibility and citation impact should be a future focus.

  2. Global Recognition and Collaboration
    There is no mention of international collaboration, editorial roles, or professional memberships, which would enhance credibility and reach.

  3. Documented Industry Linkages
    Despite some project engagement with enterprises, more evidence of sustained industry partnerships or commercialization success would strengthen the application.

  4. Books, Patents, and Conferences
    Absence of published books, patents in process, or keynote roles in international conferences limits the academic portfolio breadth.

🎓 Education:

Although specific degree details are not listed, Dr. Yang Liu has built a strong academic foundation that supports her expertise in biomedical engineering and biomechanics. Her academic journey is closely aligned with her professional role at Taiyuan University of Technology, which is known for its technical research capabilities. Dr. Liu’s knowledge spans skin tissue biology, mechanical trauma, and biomedical materials science, indicating a background that likely includes degrees in biomedical engineering, bioengineering, or a related field. Her educational experience has equipped her with the skills necessary to conduct high-level research in skin regeneration, materials science, and tissue biomechanics. Additionally, her active participation in national scientific projects and her leadership in academic innovation at the university level point to rigorous formal training and ongoing academic development.

🧪 Experience:

Dr. Yang Liu has over a decade of professional experience in biomedical research since joining the Taiyuan University of Technology in 2013. Her work has revolved around exploring the mechanical and biological factors involved in traumatic skin injury and healing. She has successfully led and contributed to multiple projects, including those funded by the National Natural Science Foundation of China and enterprise collaborations. In addition to her scientific contributions, she has also directed teaching reform projects and a patent transformation, highlighting her dual commitment to both research and education. Her experience includes a strong focus on interdisciplinary collaboration across biology, materials science, and mechanical engineering. This breadth of experience has allowed her to develop innovative biomedical materials, such as tissue-engineered skin and functional skin dressings, aimed at improving clinical treatment outcomes for burn injuries and other trauma-related skin conditions.

🔬 Research Focus:

Dr. Yang Liu’s research centers on the biomechanics of skin tissue damage and healing, with an emphasis on cutaneous trauma from burns and radiotherapy. Her work investigates how mechanical forces impact skin at multiple biological levels—molecular, cellular, tissue, and animal models. A major portion of her research explores biomedical material innovation, particularly tissue-engineered skin, skin dressings, and antibacterial materials. She is particularly focused on understanding how structural and mechanical properties of these materials can improve therapeutic outcomes. Dr. Liu also studies oxidative stress, cell migration, and protein responses under mechanical pressure, making her work crucial to trauma therapy and regenerative medicine. With a patent transformation and multiple research projects to her credit, her research is positioned at the intersection of engineering innovation and clinical application, aiming to reduce complications in skin trauma treatment and enhance recovery efficiency through scientifically engineered materials.

📚 Publications Top Notes:

  1. 🧴🧬 Preparation and characterization of nano-silver/graphene oxide antibacterial skin dressing – Scientific Reports, 2025

  2. 🔬⛽ Experimental study on liquid products and pore structure characteristics of anthracite saturated by supercritical CO₂ – Gas Science and Engineering, 2025

  3. 🧠💥 The regulatory role of the nuclear scaffold protein Emerin on the migration of amniotic epithelial cells and oxidative stress in a pressure environment – Placenta, 2025

  4. 🛠️🔥 Annealing Response of Cold-rolled Ti₂AlNb Based Alloy Foil in Different Phase Regions – Tezhong Zhuzao Ji Youse Hejin (Special Casting and Nonferrous Alloys), 2025

📝 Conclusion:

Dr. Yang Liu shows significant promise as a biomedical researcher, with a clear, focused research trajectory, practical outputs (materials for skin regeneration), and consistent project engagement at institutional and national levels. While her global visibility and citation metrics are currently limited, her research has high translational potential in trauma medicine and biomedical materials, making her a strong emerging contender for the Best Researcher Award—especially under a category recognizing early- to mid-career researchers with impactful applied science work.

Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Dr. Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Naoki Harada, Osaka Metropolitan University, Japan

Naoki Harada is an Associate Professor at Osaka Metropolitan University, Japan, with extensive expertise in molecular biology, biochemistry, endocrinology, and nutrition. He earned his Ph.D. in Life Sciences from Osaka Prefecture University in 2007. Over the past two decades, Harada has made significant contributions to understanding the physiological and biochemical mechanisms underpinning metabolic diseases, particularly type 2 diabetes. His research, characterized by high citation impact (H-index of 25), centers on pancreatic β-cell function and metabolic regulation. He has published 77 peer-reviewed articles and holds a patent related to therapeutic interventions. Harada has collaborated with leading scientists like Professors Hiroshi Inui and Ryoichi Yamaji, strengthening his academic footprint in both national and international circles. A member of multiple scientific societies, Harada continues to influence the field through impactful research, industry collaboration, and educational leadership.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Consistent Research Output

    • 77 peer-reviewed publications in reputable journals (SCI, Scopus).

    • Recent high-impact studies published in Journal of Biological Chemistry, Scientific Reports, and FASEB BioAdvances.

    • Active research profile with an H-index of 25 and over 1,785 citations.

  2. Innovative Scientific Contributions

    • Identified REDD2 as a novel therapeutic target for type 2 diabetes—bridging basic research with translational medicine.

    • Works across disciplines such as molecular biology, endocrinology, and nutritional biochemistry.

  3. Project Leadership & Industry Engagement

    • Led or participated in 14 major research projects.

    • 5 consultancy/industry-based projects, reflecting application-oriented research.

  4. Academic and Collaborative Network

    • Strong academic collaborations with Professors Hiroshi Inui and Ryoichi Yamaji.

    • Member of prestigious scientific societies (e.g., Japanese Biochemical Society, Japan Society of Nutrition and Food Science).

  5. Scientific Versatility

    • Contributions span fundamental mechanisms (e.g., oxidative stress, insulin signaling) to dietary interventions (e.g., mogrol, oleamide).

    • Demonstrates ability to bridge molecular insights with systemic physiological outcomes.

⚙️ Areas for Improvement:

  1. International Visibility and Engagement

    • Expanding participation in international conferences and editorial boards could elevate his global scientific standing.

    • Pursuing cross-border collaborations would further enrich the translational value of his work.

  2. Commercialization and Patent Activity

    • While one patent is noted, increased focus on intellectual property development and biomedical commercialization could further validate his applied research strength.

  3. Outreach and Communication

    • More active public science communication (e.g., webinars, policy advocacy, media coverage) would amplify the societal impact of his research.

🎓 Education:

Naoki Harada received his Ph.D. in Life Sciences from Osaka Prefecture University, Osaka, Japan, in September 2007. His doctoral studies laid the foundation for his interdisciplinary research in molecular biology, biochemistry, and endocrinology. Harada’s academic path was driven by a keen interest in the cellular and molecular mechanisms underlying metabolic regulation, particularly in relation to glucose homeostasis and pancreatic function. His education provided him with a solid grounding in experimental techniques, critical thinking, and scientific communication, which have become hallmarks of his later work. The institution, known for excellence in biosciences, enabled Harada to cultivate a strong research acumen. His academic training was complemented by exposure to applied research, linking basic science with clinical and nutritional applications—an approach that he has continued to emphasize throughout his career. His strong educational background plays a pivotal role in his current research endeavors and professional development.

💼 Experience:

Dr. Naoki Harada began his academic career in 2008 as an Assistant Professor at the Graduate School of Life and Environmental Sciences, Osaka Prefecture University. He was promoted to Lecturer in 2015, and subsequently to Associate Professor in 2019. Since 2022, he has served as Associate Professor at the Graduate School of Agriculture, Osaka Metropolitan University. Harada has consistently combined teaching with intensive research, mentoring graduate students while advancing his lab’s focus on metabolic diseases and endocrine physiology. His experience includes leading 14 research projects, consulting on 5 industry-linked nutrition initiatives, and co-authoring over 75 scientific papers. His experience reflects a blend of academic leadership, scientific innovation, and multidisciplinary collaboration. Notably, Harada’s role in identifying REDD2 as a therapeutic target exemplifies his contribution to translational science. He maintains strong academic partnerships and actively contributes to several professional societies, making him a respected figure in Japan’s scientific community.

🔬 Research Focus:

Naoki Harada’s research is at the intersection of molecular biology, endocrinology, and nutrition science, with a particular focus on pancreatic β-cell physiology and glucose metabolism. He investigates how oxidative stress, hormonal signals, and metabolic regulators influence insulin secretion and β-cell viability. One of his pivotal contributions is identifying the REDD2 gene as a negative regulator of β-cell function, offering novel therapeutic targets for type 2 diabetes mellitus. His studies also explore nutrient-sensing pathways, G-protein-coupled receptors, and hormonal modulation of energy metabolism. Harada’s recent work delves into the effects of dietary compounds like mogrol and oleamide on metabolic health, linking molecular mechanisms to real-world dietary interventions. His ability to bridge bench science with clinical and nutritional applications sets his research apart. Through collaborations with leading experts and high-impact publications, Harada continues to advance knowledge in the prevention and treatment of metabolic disorders.

📚 Publications Top Notes:

  • 🧬 REDD2 confers pancreatic β-cell dysfunction in high-fat diet-fed mice – Journal of Biological Chemistry, 2025

  • 🦷 Androgens suppress ST3GAL1/4, modulating mucin glycosylation and microbiota in mice – Bioscience, Biotechnology, and Biochemistry, 2025

  • 🍟 CRTC1 in MC4R cells regulates dietary fat intake – FASEB BioAdvances, 2024

  • 💉 Insulin reduces ER stress-induced apoptosis in INS-1 β-cells – Physiological Reports, 2024

  • 🍬 Mogrol activates GPBAR1 and insulin secretion, alleviates hyperglycemia – Scientific Reports, 2024

  • 🔥 Androgen receptor suppresses β-adrenoceptor-mediated thermogenesis – Journal of Biological Chemistry, 2022

  • 🏥 Age-dependent sex differences in NAFLD in TSOD and db/db mice – PLOS ONE, 2022

  • 🐭 Dietary oleamide attenuates obesity in caged mice – Bioscience, Biotechnology, and Biochemistry, 2022

  • 🌿 Curcumin targets GPR55 receptor – npj Science of Food, 2022

  • 💪 Oleamide rescues muscle atrophy in small-caged mice – British Journal of Nutrition, 2021

🧾 Conclusion:

Dr. Naoki Harada demonstrates a clear trajectory of research excellence, grounded in scientific rigor and driven by impactful biomedical questions. His ability to identify molecular mechanisms (e.g., REDD2’s role in β-cell dysfunction) and propose therapeutic directions sets him apart as a leading academic in metabolic disease research. His publication record, industry collaborations, and professional memberships underscore a mature and influential academic career.

Andrew Moran | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Dr. Andrew Moran | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Andrew Moran, University of Liverpool, United Kingdom

Dr. Andrew William Moran is a Research Associate at the University of Liverpool, UK, specializing in gastrointestinal physiology and nutrient sensing. With over two decades of research experience, his work has contributed significantly to understanding sugar sensing mechanisms and their implications for animal and human health. He holds dual honours in Biochemistry and Biological & Medicinal Chemistry from Keele University and a PhD in Biochemistry and Molecular Biology from the University of Liverpool. Dr. Moran has played key roles in industry-funded projects, notably with ADM International and Pancosma SA, contributing to patented innovations in sweetener technology. His cutting-edge research on intestinal transporters, gut hormones, and enteric nervous system function has led to over 20 peer-reviewed publications. His interdisciplinary collaborations span veterinary, nutritional, and molecular biology fields, making him a valuable asset in translational gastrointestinal science. His REF-submitted research underscores the real-world impact of his scientific contributions.

Publication Profile:  

Orcid

✅ Strengths for the Award:

  1. Robust Academic Foundation:

    • Dual honours in Biochemistry and Biological & Medicinal Chemistry (Keele University)

    • PhD in Biochemistry and Molecular Biology (University of Liverpool)

  2. Research Excellence & Impact:

    • Specializes in intestinal glucose transport, nutrient sensing, and gut-brain axis—key areas in both basic and applied science.

    • Authored 24 publications in Web of Science and 20 on PubMed, with an H-index of 15, indicating consistent impact.

  3. Translational & Applied Innovation:

    • Co-inventor on two international patents (WO2014033218A1 & WO2024121704A1) tied to sweetener additives—bridging lab discoveries with industrial application.

    • Projects funded by ADM International and Pancosma SA, highlighting industry trust.

  4. Collaborative Leadership:

    • Current research partnership with Dr. Ellen Roelfsema (Utrecht University) on metabolic syndrome in ponies—an example of cross-disciplinary collaboration.

    • Contribution to REF2021 and REF2024, showing national-level research evaluation engagement.

  5. Model Innovation:

    • Use of intestinal enteroids (mini-guts) in research, reflecting cutting-edge methodologies in gut physiology.

🧭 Areas for Improvement:

  • Editorial Leadership: There is no mention of editorial board roles or peer-review positions. Gaining visibility in editorial circles could amplify academic leadership.

  • Public Science Communication: While the research is strong, broader science communication (e.g., public outreach, open-access workshops, webinars) would further elevate his profile.

  • International Presence: While collaborations exist, a more visible presence through invited talks at global conferences or consortia could enhance reputation internationally.

🎓 Education:

Dr. Moran began his academic career with a BSc (Dual Honours) in Biochemistry and Biological & Medicinal Chemistry at Keele University from 1999 to 2002. He then pursued a PhD in Biochemistry and Molecular Biology at the University of Liverpool, completed in 2006. His doctoral work focused on molecular mechanisms governing intestinal function, laying the foundation for his future studies in gut nutrient sensing and transporter regulation. He has continually expanded his knowledge through postdoctoral training and research in gastrointestinal physiology. This includes both in vivo and in vitro experimental methodologies, ensuring a comprehensive approach to investigating intestinal health. His educational background supports a wide range of expertise—from fundamental biochemistry to applied animal nutrition and enteric neuroscience. His solid academic training is a core strength underpinning his contribution to translational and industry-focused research.

🧪 Experience:

Dr. Moran’s research experience spans over 20 years, with expertise in molecular physiology of the gastrointestinal system. Post-PhD, his early work investigated the regulation of intestinal SGLT1 transporters, combining cell-based and whole-organism experiments. From 2019 to 2022, he led a project exploring the adaptive responses of the gut to diet and development. His more recent work (2022–2024) focuses on sweetener additive development in swine, incorporating pig-specific intestinal enteroids. He is currently funded by ADM International and has previously collaborated with Pancosma SA, contributing to two international patents. Dr. Moran is also engaged in veterinary research, partnering with Utrecht University to study equine metabolic syndrome. He has served as both an academic researcher and a consultant on gut sensing and nutrient absorption. This blend of industry and academic experience strengthens his application for recognition as a leading researcher in the field of digestive sciences.

🔬 Research Focus:

Dr. Moran’s primary research interests lie in intestinal sugar and amino acid sensing, glucose transporter regulation, and the gut-brain axis. He uses both traditional and novel model systems, including intestinal enteroids (mini-guts), to explore physiological responses to dietary changes. His research particularly targets SGLT1 and GLUT2 transporters, sweet taste receptors (T1R2-T1R3), and enteroendocrine pathways, aiming to enhance feed efficiency and gut health in livestock. His focus on sweetener bioactivity has direct applications in agriculture and veterinary medicine. Additionally, Dr. Moran investigates how gut nutrient sensing influences systemic responses, including metabolic disorders like equine metabolic syndrome. By integrating biochemistry, molecular biology, and animal physiology, his research contributes to the development of functional feeds and dietary interventions. His work is highly translational, bridging laboratory research with field application, and has resulted in two patents, several international collaborations, and over 20 peer-reviewed journal articles, with research submitted for REF2021 and REF2024.

📚 Publications Top Notes:

  1. 📄 Luminal Sweet Sensing and Enteric Nervous System Participate in Regulation of Intestinal Glucose Transporter, GLUT2

  2. 📄 Nutrient sensing of gut luminal environment (Symposium: Proceedings of the Nutrition Society)

  3. 📄 Non-nutritive sweetener activation of the pig sweet taste receptor T1R2-T1R3 in vitro mirrors gut expression

  4. 📄 Toll-like receptor 9 in intestinal enteroendocrine cells induces cholecystokinin secretion

  5. 📄 High-Intensity Sweetener Enhances Intestinal SGLT1 and Improves Enteric Disorders in Rabbits

  6. 📄 Effect of Milk Replacer Composition on Intestinal Microbiota of Pre-ruminant Dairy Calves

  7. 📄 Host selectively shapes intestinal microbiota of carnivorous and omnivorous fish

  8. 📄 GLP-2 and Enteric Nervous System Regulate Intestinal Na+/Glucose Co-transport

  9. 📄 Deregulation of transcription factors in morbidly obese affects enteroendocrine cells

  10. 📄 Composition and diversity of pig gastrointestinal mucosa-associated microbiota under dietary influence

📝 Conclusion:

Dr. Andrew William Moran presents a strong and diverse research portfolio with a notable balance between fundamental science and industrial relevance. His innovation in nutrient sensing and gut physiology, coupled with active collaborations and patentable outputs, makes him an ideal candidate for the Best Researcher Award. With minor expansion in academic leadership and public engagement, Dr. Moran is poised to become a prominent figure in translational biosciences globally.

minghe luo | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Mr. minghe luo | Microbial Cell Biology | Best Researcher Award

Mr. minghe luo , Chongqing University of Technology , China

Dr. Minghe Luo, born in April 1984, is an accomplished pharmaceutical scientist and Associate Professor at Chongqing University of Technology. Specializing in natural product biosynthesis, he has made significant contributions to the discovery of novel antibiotics and the mechanistic understanding of biosynthetic pathways from marine microorganisms. His academic journey has taken him through respected institutions including Wuhan University and Southwest University, with extensive research training at the South China Sea Institute of Oceanology. Known for his collaborative spirit and deep expertise in medicinal chemistry, Dr. Luo has authored numerous impactful publications in journals like Angewandte Chemie and Organic Letters. His work not only advances scientific knowledge but also offers practical implications for antibiotic development. A dedicated educator and researcher, Dr. Luo continues to explore microbial biosynthetic machinery, aiming to discover new therapeutics for drug-resistant infections.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Depth of Expertise:
    Dr. Luo has solid academic foundations with a PhD in Pharmacy and a Master’s in Medicinal Chemistry of Natural Products. His specialty in natural products biosynthesis—particularly from marine microorganisms—positions him uniquely in pharmaceutical research.

  2. Research Output & Impact:
    He has authored over 15 research papers in high-impact journals such as Angewandte Chemie, Organic Letters, Chemical Engineering Journal, and Journal of Natural Products. His work tackles urgent global needs, like antibiotic resistance, with research on compounds targeting MRSA and other drug-resistant pathogens.

  3. Innovation in Biosynthesis:
    His research on trans-AT polyketide synthases, novel biosynthetic pathways, and genome mining for cryptic natural products exemplifies forward-thinking, interdisciplinary science.

  4. Independent Research and Teaching:
    As an Associate Professor, he leads independent projects while teaching and mentoring students—demonstrating both leadership and academic service.

  5. Collaboration:
    His co-authored papers reflect strong collaborative ties, including with international researchers like Prof. Jeroen Dickschat (Germany), a mark of scientific credibility and connectivity.

⚠️ Areas for Improvement:

  1. Patent/Translational Outputs:
    While his publications are excellent, showcasing patents, industry collaborations, or drug development pipelines would better demonstrate translational relevance.

  2. Global Outreach:
    Participation in international conferences, scientific boards, or as an editorial reviewer could enhance his global visibility.

  3. Public Engagement:
    Greater involvement in public science communication or outreach could boost his societal impact profile.

🎓 Education:

Dr. Minghe Luo earned his Doctorate in Pharmacy from Wuhan University (2018–2021), under the supervision of Prof. Yuhui Sun, focusing on the biosynthesis of natural products. Prior to this, he completed a Master’s degree in Medicinal Chemistry of Natural Products through a joint program between Southwest University and the South China Sea Institute of Oceanology (2008–2011), guided by Professors Zichuan Bai and Jianhua Ju. His postgraduate training emphasized the chemical characterization and bioactivity of marine-derived fungal metabolites. This unique blend of pharmacy and chemistry, alongside rigorous experimental research, laid the foundation for his expertise in microbial natural product discovery and biosynthesis. Dr. Luo’s academic development reflects a deep commitment to both theoretical understanding and applied research, equipping him with the tools to lead investigations into novel bioactive compounds, particularly those from extreme marine environments.

💼 Experience:

Dr. Luo began his career as a research scientist at the Third Affiliated Hospital of the Third Military Medical University (2011–2018), focusing on microbial natural product discovery. In 2021, he joined Chongqing University of Technology as an Associate Professor, where he leads independent projects on biosynthetic pathway elucidation and engineering of marine microbial metabolites. His role includes teaching pharmacy courses and mentoring graduate students. Dr. Luo’s experience spans isolation, structural elucidation, and genetic manipulation of microbial strains to unlock cryptic biosynthetic potential. His consistent publication record demonstrates both foundational research and innovative biosynthetic strategies. Over the years, he has cultivated a reputation for high-quality research and collaborative spirit, contributing significantly to antibiotic and anticancer compound discovery pipelines. He is particularly recognized for exploring deep-sea actinomycetes, making meaningful strides in developing novel antibacterial agents against drug-resistant pathogens.

🔬 Research Focus:

Dr. Luo’s research centers on the biosynthesis of microbial natural products, particularly from marine-derived actinomycetes and fungi. His primary interests include identifying novel polyketides, non-ribosomal peptides, and hybrid metabolites with antibacterial or anticancer potential. He employs genome mining, biosynthetic gene cluster (BGC) characterization, and pathway engineering to discover and optimize the production of bioactive compounds. A key theme in his work is understanding the mechanisms of tailoring enzymes (e.g., methyltransferases, P450s, dehydrating modules) that diversify natural product structures. Dr. Luo has also made major strides in elucidating biosynthetic pathways like those for hangtaimycin and streptovaricins. He is passionate about translating his findings into new drug leads, particularly targeting MRSA and multi-drug-resistant infections. His interdisciplinary approach bridges organic chemistry, synthetic biology, and pharmacology, contributing to the broader field of drug discovery from marine natural sources.

📚 Publications Top Notes:

  1. 🧪 The mechanism of dehydrating bimodules in trans-AT polyketide biosynthesis: hangtaimycin study – Angew. Chem. Int. Edit.

  2. 🧬 Methylation in hangtaimycin biosynthesis and its antibacterial activities – Synth. Syst. Biotechnol.

  3. 💊 Local delivery of deep marine equisetin via PVP nanofibers for anti-MRSA – Chem. Eng. J.

  4. 🌊 Natural siderophore acremonpeptides and their aluminum complex from Acremonium – J. Nat. Prod.

  5. 🔬 Amino acid-conjugated anthraquinones from marine Penicillium sp. – J. Nat. Prod.

  6. 🌐 Halogenated anthraquinones from Aspergillus sp. – J. Nat. Prod.

  7. 🧫 Genome-based mining of carpatamides I–M and their biosynthetic gene cluster – Mar. Drugs

  8. 🌿 Antibacterial lobophorin L and M from marine Streptomyces sp. – Nat. Prod. Res.

  9. 🧪 Two new streptovaricin derivatives from Streptomyces spectabilis mutants – Nat. Prod. Res.

  10. ⚗️ Mycophenolic acid derivative from Penicillium sp. fermentation – Nat. Prod. Res.

🧾 Conclusion:

Dr. Minghe Luo clearly exhibits the scientific rigor, innovation, and productivity deserving of the Best Researcher Award. His contributions to the field of natural product chemistry and biosynthesis, especially in the context of antimicrobial resistance, are both timely and impactful. With minor improvements in translational output and international visibility, he is poised to become a leading figure globally in pharmaceutical biotechnology.

Alessandra Luchini | Cell-Cell Communication | Best Researcher Award

Published on by Cell Biologist

Prof. Alessandra Luchini | Cell-Cell Communication | Best Researcher Award

Prof. Alessandra Luchini , George Mason University , United States

Dr. Alessandra Luchini is a tenured professor at George Mason University in the School of Systems Biology and serves as Director of the Biosciences Ph.D. Program. A native of Italy, she holds a Ph.D. in Bioengineering and a degree in Chemical Engineering cum laude from the University of Padova. She completed her postdoctoral training in proteomics and nanotechnology at George Mason University. Dr. Luchini’s pioneering research integrates nanotechnology with biomedical diagnostics to enhance disease detection and treatment, particularly in cancer, infectious, and inflammatory diseases. She has co-authored numerous peer-reviewed publications and is a co-inventor on several patents. Dr. Luchini also co-founded two biotech companies: Ceres Nanosciences and Monet Pharmaceuticals. Recognized nationally and internationally, she was named one of Popular Science’s “Brilliant 10” and received Virginia’s Outstanding Faculty Award in 2023. Her work bridges academia, innovation, and industry in pursuit of transformative healthcare solutions.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Distinguished Academic and Leadership Role: Tenured professor and director of the Ph.D. Biosciences program at George Mason University, reflecting leadership in both research and education.

  2. Innovative Translational Research: Her work bridges nanotechnology and proteomics to create real-world diagnostic solutions, particularly for cancer, infectious diseases, and neurological conditions.

  3. Entrepreneurial Impact: Co-founder of two biotech companies (Ceres Nanosciences and Monet Pharmaceuticals) that commercialize her academic innovations, demonstrating translational relevance.

  4. Recognition and Awards: Named among the “Brilliant 10” by Popular Science (2011) and recipient of the Virginia Outstanding Faculty Award (2023), showcasing external validation of excellence.

  5. Scientific Productivity: Author of peer-reviewed publications across high-impact journals with an H-index of 31, indicating influence and citation of her work.

  6. Active Research Funding: Current DoD-funded project as Principal Investigator on Lyme disease diagnostics reflects continued support and relevance of her work.

🔍 Areas for Improvement:

  1. Wider Global Collaboration: While she has excellent U.S. academic and biotech engagement, increasing international collaborations (e.g., with European or Asian institutions) could enhance global research impact.

  2. Public Science Communication: Dr. Luchini’s impactful research could benefit from more visibility in mainstream science communication outlets or public forums, particularly on topics like microbiome and cancer diagnostics.

  3. Mentorship Metrics: While she leads a Ph.D. program, formal documentation of mentorship outcomes (e.g., student success stories, awards) could further strengthen her educational impact profile

🎓 Education:

Dr. Alessandra Luchini’s educational journey began in Italy at the prestigious University of Padova, where she earned her degree in Chemical Engineering cum laude. Driven by her passion for biomedical innovation, she pursued a Ph.D. in Bioengineering at the same institution, graduating in 2005. Her doctoral studies provided a foundation in the integration of engineering principles with life sciences, focusing on biomolecular processes. In 2007, she completed postdoctoral training in Proteomics and Nanotechnology at George Mason University in the United States. This specialized training equipped her with expertise in advanced diagnostic tools and molecular profiling technologies. Her educational background uniquely combines strong engineering fundamentals with deep biological insight, allowing her to develop groundbreaking diagnostic platforms and translational research that bridges basic science with clinical applications. Dr. Luchini’s academic credentials laid the groundwork for a prolific research career in bioengineering, nanomedicine, and systems biology.

🧪 Experience:

Dr. Luchini began her U.S.-based academic career at George Mason University in 2007 and has steadily advanced to the role of Professor with tenure since 2020 in the School of Systems Biology. She has served as Graduate Program Director for the Ph.D. in Biosciences since 2019. Her leadership extends beyond the classroom, guiding graduate students and junior researchers in fields such as proteomics, nanotechnology, and infectious disease diagnostics. From 2015 to 2020, she was an Associate Professor and contributed extensively to curriculum development and translational research. Dr. Luchini has also co-founded Ceres Nanosciences (2008) and Monet Pharmaceuticals (2019), which commercialize technologies stemming from her research. Her interdisciplinary work spans collaboration with immunologists, chemists, and clinicians, contributing to large-scale projects funded by entities such as the U.S. Army. Her experience reflects a rare blend of academic rigor, entrepreneurial drive, and real-world impact.

🏅 Awards and Honors:

Dr. Alessandra Luchini’s excellence in research and education has earned her prestigious recognitions. In 2023, she was honored with the Outstanding Faculty Award by the State Council of Higher Education for Virginia, the highest faculty award in the state. She was previously named one of Popular Science’s “Brilliant 10” scientists in 2011, highlighting her innovative contributions to nanotechnology and disease diagnostics. These honors underscore her leadership in biomedical engineering, translational research, and mentorship. Dr. Luchini has also been a Principal Investigator on numerous federally funded research projects and holds several issued patents in proteomic diagnostics, which have led to real-world biotech applications. Her scientific impact is reflected in an H-index of 31, showcasing her influential publication record. She is also recognized for public engagement, contributing to both academic and industrial innovation. These achievements solidify her as a leading candidate for a Best Researcher Award.

🔬 Research Focus:

Dr. Alessandra Luchini’s research lies at the intersection of proteomics, nanotechnology, and molecular diagnostics. Her core aim is to improve early detection and therapeutic strategies for diseases such as cancer, Lyme disease, tuberculosis, and neurological disorders. She is a recognized leader in the development of affinity nanoparticle platforms, enabling the capture of disease biomarkers from biofluids like urine and saliva. Recent studies explore how bacterial extracellular vesicles affect calcium signaling in breast cancer, revealing new pathways for early intervention. Her work in protein painting mass spectrometry identifies key binding sites relevant to autoimmune and infectious diseases, while her collaborations with biotech firms bring these discoveries into diagnostic tools. Dr. Luchini is known for applying systems biology to real-world clinical problems, translating lab findings into impactful solutions. Her research integrates computational biology, clinical proteomics, and nanomaterials to open new frontiers in personalized medicine and public health diagnostics.

📚 Publications Top Notes:

  1. 🧫 Urinary bacteriophage cooperation with bacterial pathogens… – Commun Biol, 2025

  2. 🧪 Urinary Borrelia Peptides Correlate with GSQ-30 Scores… – J Cell Immunol, 2025

  3. 🧏 Hearing Science Accelerator: Sudden Sensorineural Hearing Loss… – Otol Neurotol, 2024

  4. 🧬 A set of diagnostic tests for detection of active Babesia duncani… – Int J Infect Dis, 2024

  5. 🧠 Protein Painting Mass Spectrometry in Discovery of Interaction Sites… – ACS Chem Neurosci, 2024

  6. 🖼️ Wheat-Based Glues in Conservation and Cultural Heritage… – J Proteome Res, 2024

  7. 🧬 Identification of Unambiguous Borrelia Peptides… – Methods Mol Biol, 2024

  8. 🧠 Molecular profiling reveals nucleoside metabolism in medulloblastoma… – Acta Neuropathol Commun, 2023

  9. 🧬 PD-L1 Interface Region Responsible for PD-1 Binding… – J Biol Chem, 2023

  10. 💊 Drug discovery efforts at George Mason University… – SLAS Discov, 2023

🧾 Conclusion:

Dr. Alessandra Luchini is exceptionally well-qualified for a Best Researcher Award. Her unique combination of high-impact research, translational innovation, academic leadership, and entrepreneurial success places her in the top tier of candidates. Her multidisciplinary approach—spanning bioengineering, nanomedicine, and molecular diagnostics—addresses some of the most pressing challenges in modern medicine. While minor areas such as broader global outreach and science communication could be enhanced, these do not diminish her outstanding achievements. Her track record reflects both depth and breadth of contribution, making her a strong, deserving candidate for this recognition.

Noura Hussein Abdel Hamid | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Noura Hussein Abdel Hamid | Cell Structure Analysis | Best Researcher Award

Assist. Prof. Dr. Noura Hussein Abdel Hamid , Zagazig University , Egypt

Dr. Noura Hussein Abedel Hamid Mekawy is a dedicated Egyptian medical academic with extensive expertise in Histology and Cell Biology. Born on April 18, 1981, she graduated with an M.B.B.Ch. from Zagazig University in 2006, followed by a Master’s (2012) and an M.D. (2017) in Histology and Cell Biology from the same institution. Currently, she serves as a Lecturer at Zagazig University’s Faculty of Medicine. Her academic journey is complemented by her passion for medical education, microscopy, and molecular research. Dr. Mekawy has contributed to the field with multiple publications in reputable scientific journals, focusing on histopathological and immunohistochemical studies. She is a member of the Egyptian Society of Histology and Cytology and has completed professional training in self-evaluation and quality assurance in higher education. Her commitment to scientific advancement and education has established her as a respected figure in medical academia.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Extensive Research Background
    Dr. Mekawy has authored and co-authored 10 peer-reviewed publications, focusing on histopathology, immunohistochemistry, toxicology, and therapeutic interventions in experimental models.

  2. Specialization in a Vital Medical Field
    Her focus on Histology and Cell Biology is crucial for understanding disease mechanisms and developing new treatment strategies.

  3. Academic Progression & Teaching Role
    She has shown consistent career advancement from Demonstrator to Lecturer, demonstrating leadership and commitment in academia.

  4. Diverse Research Themes
    Her work explores the toxicological impacts of nanoparticles, pharmaceuticals, and environmental exposures, as well as the protective effects of antioxidants and stem cells—offering a well-rounded scientific profile.

  5. Professional Engagement
    Active member of Egyptian Society of Histology and Cytology and Medical Professions Syndicate, and involved in scientific conferences and training workshops.

  6. Methodological Strength
    Her skills in light/electron microscopy and immunohistochemical techniques indicate deep technical expertise.

⚙️ Areas for Improvement:

  1. Expand to International Collaborations
    Engaging in collaborative research with international institutions can increase visibility and impact.

  2. Publication in Higher Impact Journals
    While she has multiple publications, targeting high-impact Q1 journals can elevate the academic value of her research.

  3. Grant Funding & Project Leadership
    Applying for external research grants and leading funded projects would further enhance her research profile.

  4. Clinical Translation
    Bridging her findings from animal studies to clinical or translational research can broaden applicability.

🎓 Education:

Dr. Noura Mekawy earned her M.B.B.Ch. degree in Medicine and General Surgery from Zagazig University in October 2006, graduating with an excellent grade. Her strong academic foundation led her to pursue postgraduate studies in Histology and Cell Biology. In May 2012, she was awarded a Master’s degree with a thesis titled “The Effect of Maternal Exposure to Di (2-ethylhexyl) phthalate on The Lung of Albino Rat Offspring (Histological and Immunohistochemical Study).” She continued her academic progression by earning her M.D. in Basic Medical Sciences (Histology and Cell Biology) in January 2017. Throughout her studies, Dr. Mekawy demonstrated outstanding academic performance and developed a deep interest in cellular biology and histopathology. Her educational background reflects her commitment to advancing medical science through both practical research and academic instruction.

🧪 Experience:

Dr. Noura Mekawy began her academic career as a Demonstrator in the Histology and Cell Biology Department at Zagazig University in August 2008. She served in this role until May 2012, when she was promoted to Assistant Lecturer. In January 2017, following the completion of her M.D., she assumed the position of Lecturer in the same department. With over 15 years of experience in teaching and laboratory work, Dr. Mekawy has become proficient in histological techniques, immunohistochemistry, and electron microscopy. She is also skilled in data analysis using SPSS and Microsoft Office tools. Her responsibilities include teaching, supervising research projects, and contributing to curriculum development. Additionally, she has participated in educational quality assurance workshops and continues to mentor students and junior faculty members. Her teaching experience, combined with hands-on laboratory expertise, makes her a well-rounded educator and researcher.

🔬 Research Focus:

Dr. Mekawy’s research primarily focuses on histopathological and immunohistochemical changes in response to environmental, chemical, and pharmaceutical exposures in animal models. Her investigations are centered on understanding tissue damage and repair mechanisms in organs like the liver, lungs, testes, heart, submandibular glands, and the central nervous system. A consistent theme across her work is evaluating the protective or therapeutic roles of natural substances and pharmacological agents, including antioxidants like Vitamin E, Nigella sativa, and Zingerone, as well as advanced treatments such as salivary exosomes and stem cells. She integrates light microscopy, electron microscopy, and molecular biology techniques in her research. Dr. Mekawy is also engaged in evaluating the histological effects of nanoparticles and energy drinks on various tissues. Her contributions are valuable for toxicological assessment and potential therapeutic innovations, contributing to public health and medical safety.

📚 Publications Top Notes:

  1. 🧪 Effect of Silver Nanoparticles on Testes of Prepubertal Male Albino Rats and the Possible Protective Role of Vitamin E

  2. ⚠️ Hepatic Changes under the Effect of Red Bull Energy Drinks and its Withdrawal in Adult Male Albino Rats

  3. 💧 Therapeutic Role of Salivary Exosomes in Improving Histological and Biochemical Changes Induced by Duct Ligation in Submandibular Glands

  4. ❤️ The Possible Protective Effect of Zingiber Officinale on Cyclophosphamide-Induced Cardiotoxicity

  5. 👁️ Protective Effect of Chrysin on Corneal Structural Alterations Induced by Sofosbuvir

  6. 🧬 Nicorandil and Bone Marrow-Derived Mesenchymal Stem Cells in Ureteric Obstruction Recovery

  7. 🧠 Effect of Zinc Oxide Nanoparticles on Cerebellar Cortex of Adult Male Albino Rats

  8. 🥼 Protective Role of Ghrelin versus its Combination with Zingerone on Gastric Ischemic-Reperfusion

  9. 🔊 Effect of Low Frequency Noise on Heart and Lung & Role of Vitamin C

  10. 💪 Nandrolone Effect on Cardiac Muscle and Role of Nigella Sativa

🧾 Conclusion:

Dr. Noura Mekawy exhibits the hallmarks of a dedicated, capable, and innovative researcher in medical science. With over a decade of academic and research experience, she has made valuable contributions to experimental histology and cell biology. Her work is methodologically sound, thematically diverse, and medically relevant. The strength of her research, consistent publication record, and academic integrity make her a highly suitable candidate for the Best Researcher Award. Continued growth in publication quality, global collaboration, and translational research will further enhance her already impressive academic journey.